The agency that runs India's public health insurance for the poorest 40% of the population, which pays for cancer surgery, chemotherapy and radiotherapy up to a yearly limit per family.
Ayushman Bharat Pradhan Mantri Jan Arogya Yojana was launched on 23 September 2018 and is administered by the National Health Authority with state health agencies. It offers a cashless cover of 5 lakh rupees per family per year for secondary and tertiary hospital care to roughly the poorest 40% of Indians (the original target was about 10 crore households, around 50 crore people), and in September 2024 was extended to everyone aged 70 and over regardless of income. Oncology packages (surgery, chemotherapy, radiotherapy and supportive care) are among the most used tertiary benefits, and public and empanelled private cancer hospitals, including the Tata Memorial units, treat PM-JAY patients.
Evidence so far: a 2025 study of 6,695 cancer patients at seven centres in six states found that PM-JAY enrolment was associated with a large improvement in starting treatment within 30 days of diagnosis, and that patients diagnosed after 2018 had 36% higher odds of timely treatment than those diagnosed earlier. Gaps remain: outpatient care, most oral drugs and diagnostics are outside the cover, and package rates for newer drugs are low.
One institution page on OnCo cites this paper by its DOI; this record gives the citation a page of its own so a reader can follow it without leaving OnCo. Read the abstract above alongside the citing page listed under Related; the record was created automatically from the Europe PMC entry and its figures have not been checked by hand.
India's cancer problem is a late-diagnosis problem as much as a treatment problem: the same cancers that dominate (oral, cervical, breast) are the ones screening and vaccination can prevent or catch early. The numbers set the priorities of the National Cancer Grid, PM-JAY oncology packages and the national screening programme.
Shares National Cancer Grid of India, Global oncology and access in low- and middle-income countries, Tata Memorial Centre, Prices and value.
Shares National Cancer Grid of India, Global oncology and access in low- and middle-income countries, Tata Memorial Centre, Prices and value.
Shares National Cancer Grid of India, Global oncology and access in low- and middle-income countries, Tata Memorial Centre, Most of the world has almost no cancer care.
Shares Global oncology and access in low- and middle-income countries, Prices and value, Most of the world has almost no cancer care.
Shares The new AIIMS network (PMSSY), National Cancer Grid of India, Global oncology and access in low- and middle-income countries.
Shares National Cancer Grid of India, Global oncology and access in low- and middle-income countries, Tata Memorial Centre.
Shares Tata Memorial Centre, Most of the world has almost no cancer care.
Shares National Cancer Grid of India, Global oncology and access in low- and middle-income countries.